{
    "organizations": [],
    "uuid": "4986c46813eea11521424131f9a7605e9bc23dd3",
    "author": "",
    "url": "https://in.reuters.com/video/2018/04/25/takeda-sweetens-the-pill-for-shire-with?videoId=421101581",
    "ord_in_thread": 0,
    "title": "Takeda sweetens the pill for Shire with $64 billion takeover offer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Takeda sweetens the pill for Shire with $64 billion takeover offer Wednesday, April 25, 2018 - 01:51\nRare disease specialist Shire says it is willing to recommend a sweetened $64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company this year. Silvia Antonioli reports.\nRare disease specialist Shire says it is willing to recommend a sweetened $64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company this year. Silvia Antonioli reports. //reut.rs/2r0ZSDM",
    "published": "2018-04-25T14:58:00.000+03:00",
    "crawled": "2018-04-25T15:45:16.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "takeda",
        "sweetens",
        "pill",
        "shire",
        "billion",
        "takeover",
        "offer",
        "wednesday",
        "april",
        "rare",
        "disease",
        "specialist",
        "shire",
        "say",
        "willing",
        "recommend",
        "sweetened",
        "billion",
        "offer",
        "japan",
        "takeda",
        "pharmaceutical",
        "co",
        "shareholder",
        "would",
        "biggest",
        "acquisition",
        "drug",
        "company",
        "year",
        "silvia",
        "antonioli",
        "report",
        "rare",
        "disease",
        "specialist",
        "shire",
        "say",
        "willing",
        "recommend",
        "sweetened",
        "billion",
        "offer",
        "japan",
        "takeda",
        "pharmaceutical",
        "co",
        "shareholder",
        "would",
        "biggest",
        "acquisition",
        "drug",
        "company",
        "year",
        "silvia",
        "antonioli",
        "report"
    ]
}